Hemoglobin SC Disease
Showing 1 - 25 of >10,000
Sickle Cell Disease, Sickle Beta Zero Thalassemia, Sickle B+ Thalassemia Trial in Chicago (MED-Go App)
Recruiting
- Sickle Cell Disease
- +3 more
- MED-Go App
-
Chicago, IllinoisAnn & Robert H Lurie Children's Hospital of Chicago
Mar 7, 2022
Hemoglobin SC Disease, Anemia, Sickle Cell Trial in Miami (Parent Educational Support)
Completed
- Hemoglobin SC Disease
- Anemia, Sickle Cell
- Parent Educational Support
-
Miami, FloridaMailman Center for Child Development
Jul 26, 2021
Hemoglobin SC Disease Trial in Houston (hydroxyurea)
Terminated
- Hemoglobin SC Disease
-
Houston, TexasTexas Children's Hospital
Sep 8, 2020
Sickle Cell Disease, Sickle B+ Thalassemia, Sickle Beta Zero Thalassemia Trial in Chicago (HU-Go app)
Completed
- Sickle Cell Disease
- +3 more
- HU-Go app
-
Chicago, IllinoisAnn & Robert H Lurie Children's Hospital of Chicago
Jul 27, 2021
Sickle Cell Hemoglobin C Disease, Hemoglobin S Disease Trial in France (Training Program)
Completed
- Sickle Cell Hemoglobin C Disease
- Hemoglobin S Disease
- Training Program
-
Bobigny, France
- +8 more
Sep 6, 2021
Sickle Cell Disease, Sickle Cell Hemoglobin C, Sickle Beta Zero Thalassemia Trial in Chicago (PROs assessment using sickle cell
Completed
- Sickle Cell Disease
- +3 more
- PROs assessment using sickle cell disease mobile app (SCD-app)
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago
Dec 17, 2020
Sickle Cell Disease, Hemoglobin SC Trial in Houston (Busulfan, Campath 1H, Cyclophosphamide and MESNA)
Alpha Thalassemia Hemoglobin H Constant Spring, Hemoglobinopathies, Hereditary Diseases Trial in Nanning (RM-004)
Recruiting
- Alpha Thalassemia Hemoglobin H Constant Spring
- +2 more
- RM-004
-
Nanning, Guangxi, ChinaThe 923rd Hospital of Joint Logistics Support Force of People's
Oct 25, 2023
Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)
Not yet recruiting
- Ulcerative Colitis
- Crohn's Disease
- Vedolizumab IV
- Vedolizumab SC
- (no location specified)
Oct 17, 2023
Crohn's Disease Trial in Warszawa (CT-P13 SC (Infliximab), Placebo SC)
Active, not recruiting
- Crohn's Disease
- CT-P13 SC (Infliximab)
- Placebo SC
-
Warszawa, PolandWIP Warsaw IBD Point Profesor Kierkus
Dec 6, 2022
Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)
Not yet recruiting
- Crohn's Disease
- Risankizumab SC
- Placebo for risankizumab
- (no location specified)
Sep 26, 2023
Dyslipidemias, Hyperglycemia, Liver Dysfunction Trial in Karachi (Ajwa Date (phoenix dactylifera))
Unknown status
- Dyslipidemias
- +5 more
- Ajwa Date (phoenix dactylifera)
-
Karachi, Sindh, PakistanAga Khan University
Nov 7, 2019
Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
- Sickle Cell Disease
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 21, 2023
Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)
Recruiting
- Alzheimer Disease
- GB-5001A
- +2 more
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Nov 17, 2023
Crohn's Disease Trial in Seoul (Infliximab-Dyyb)
Not yet recruiting
- Crohn's Disease
-
Seoul, Korea, Republic ofAsan Medical Center
Oct 5, 2023
Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)
Not yet recruiting
- Diabetic Kidney Disease
- IgA Nephropathy
- Placebo of SC0062
- +3 more
- (no location specified)
Jan 9, 2023
Von Willebrand Diseases Trial in Vienna (VGA039, Placebo)
Recruiting
- Von Willebrand Diseases
- VGA039
- Placebo
-
Vienna, AustriaMedical University of Vienna
Mar 20, 2023
Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)
Recruiting
- Sickle Cell Disease
- OTQ923
-
Los Angeles, California
- +4 more
Jan 9, 2023
Sickle Cell Disease Trial in Boston (Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA
Recruiting
- Sickle Cell Disease
- Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA targeting BCL11a
-
Los Angeles, California
- +8 more
Jan 10, 2023
Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)
Recruiting
- Sickle Cell Disease
- +2 more
- HDL2
-
Pointe-à-Pitre, Guadeloupe, France
- +1 more
Mar 21, 2023
Perianal Fistula, Crohn's Disease Trial (Human TH-SC01 cell injection)
Not yet recruiting
- Perianal Fistula
- Crohn's Disease
- Human TH-SC01 cell injection
- (no location specified)
Nov 15, 2022
Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)
Not yet recruiting
- Crohn's Disease
- Vedolizumab
- +2 more
-
Chicago, IllinoisUniversity of Chicago Medicine
Sep 13, 2023